AndreaM.MilbourneMD
Obstetrics & Gynecology • Houston, TXGynecologic Oncology
UTMD Anderson Cancer Center
Dr. Milbourne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterResidency, Obstetrics and Gynecology, 1992 - 1996
University of Hawaii, John A. Burns School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1994 - Present
FL State Medical License 2021 - Present
WA State Medical License 2023 - 2026
AZ State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device Start of enrollment: 2007 May 01
- Collection of Outcomes Data for Pregnant Patients With Cancer Start of enrollment: 2005 Dec 19
Publications & Presentations
PubMed
- Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single-inst...Elizabeth Davaro, Agata A Tinnirello, Therese B Bevers, Andrea Milbourne, Roland Bassett
Cancer Cytopathology. 2024-03-01 - 1 citationsAddressing cervical cancer disparities in Texas: Expansion of a community-based prevention initiative for medically underserved populations.Samantha H Batman, Melissa L Varon, Maria Daheri, Tony Ogburn, Saul D Rivas
Preventive Medicine Reports. 2023-12-01 - 1 citationsScanning darkfield high-resolution microendoscope for label-free microvascular imaging.Huayu Hou, Yubo Tang, Jackson B Coole, Alex Kortum, Richard A Schwarz
Biomedical Optics Express. 2023-10-01
Journal Articles
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerShannon N Westin, Lois M Ramondetta, Kathleen M Schmeler, Pamela T Soliman, Nicole D Fleming, Jennifer K Burzawa, Alpa M Nick, Andrea M Milbourne, Diane C Bodurka, Rob..., American Journal of Obstetrics and Gynecology
Other
- Heavy or irregular uterine bleeding during chemotherapyMilbourne A
http://www.uptodate.com/contents/heavy-or-irregular-uterine-bleeding-during-chemotherapy
UpToDate, Wolters Kluwer Health - 2012-11-27
Authored Content
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
Press Mentions
- New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 YearsNovember 6th, 2020
Updated Cervical Cancer Screening Guidelines: What to KnowJuly 31st, 2020- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) (ART-CIN_IIB)September 23rd, 2019
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- German, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
